ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO209

SNX19 and p27 kip1 Regulate D1R Endocytosis in Renal Proximal Tubule Cells

Session Information

Category: Hypertension and CVD

  • 1601 Hypertension and CVD: Basic

Authors

  • Amatya, Bibhas, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Asico, Laureano D., The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Feranil, Jun, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Campisi Cadme, Raisha L., The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Polzin, Jacob Quentin Mullins, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Armando, Ines, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Felder, Robin Allen, University of Virginia, Charlottesville, Virginia, United States
  • Jose, Pedro A., The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Lee, Hewang, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
Background

SNX19, a member of the SNX-PXA-RGS-PXC subfamily of sorting nexin proteins, is localized in lipid raft microdomains and regulates dopamine D1 receptor (D1R) endocytosis, renal sodium transport, and subsequently blood pressure. The interaction between SNX19 and p27Kip1, a scaffold protein in lipid rafts, in the regulation of D1R endocytosis is unknown.

Methods

Colocalization was observed by confocal immunofluorescence microscopy; protein-protein interaction was determined by co-immunoprecipitation. Blood pressure was measured in conscious C57BL/6 mice treated with a 7-day renal subcapsular infusion of Snx19 siRNA; mock siRNA served as the control.

Results

In human renal proximal tubule cells (RPTCs), SNX19 colocalized with caveolin-1 and flotillin-1. SNX19 and caveolin-1 or flotillin-1 also co-immunoprecipitated in human RPTCs. Fenoldopam (FEN, 25 nM, 30 mins, n=3), a D1R/D5R agonist, increased their co-immunoprecipitation. Interestingly, p27Kip1, a canonical cyclin-dependent kinase inhibitor, colocalized with calveolin-1 and flotillin-1 in mouse and human RPTCs, confirming electron and confocal microscopic studies that p27Kip1 is a lipid raft protein. Confocal immunofluorescence microscopy showed that in mouse RPTCs, FEN (25nM, 30 min) increased the colocalization of p27Kip1 with α-tubulin which is essential in SNX19-mediated D1R endocytosis. The D1R/D5R antagonist, Sch 39916 (SCH, 1 µM, 30 min), prevented the FEN-mediated increase in the colocalization of p27Kip1 with α-tubulin. Moreover, nocodazole (10 µM, 1hr), a microtubule depolymerization inhibitor, interfered with the FEN-mediated increase in the colocalization of SNX19 with D1R, confirming the importance of the microtubule in the SNX19-mediated D1R endocytosis. The D1R is downstream of SNX19 because silencing DRD1 in human RPTCs decreased D1R but not SNX19 expression. SNX19 and D1R play a role in blood pressure regulation. In C57BL/6 mice on a normal salt diet (0.9% NaCl), renal subcapsular infusion of Snx19 siRNA (3 mg/day; 7 days) increased systolic BP (mock siRNA: 99.3 ± 1.52 mmHg, n=3; Snx19 siRNA: 114.1 ± 5.44 mmHg, n=3) and decreased renal D1R expression.

Conclusion

SNX19 in the RPT interacts with p27Kip1 in the lipid rafts to regulate SNX19-mediated D1R endocytosis and subsequently, blood pressure.

Funding

  • NIDDK Support